YAP1 and obesity disorder: Furthermore, using verteporfin as a chemical genetic tool to disrupt the YAP/TAZ–TEADs axis after the onset of AT tissue fibrosis, we found that the obesity-induced fibrosis was largely ameliorated by the treatment.